Eternity Healthcare to Initiate a Large Scale Clinical Trial of Its Needle-Free Injection System in Patients Undergoing Fertility Treatments Using the Drug Gonadotropins

Business Wire


Eternity Healthcare Inc. (ETAH), a medical device and diagnostic company, announced today that they have signed an agreement with a major fertility clinic, Pacific Center for Reproductive Medicine. Eternity Healthcare and Pacific Center for Reproductive Medicine (PCRM) will partner for a large clinical trial that will use the Comfort-in™ Needle-Free Injection System in PCRM patients undergoing fertility treatments using the drug Gonadotropins.

The clinical trial will involve as many as 60 female patients that are requiring stimulation by the fertility drug Gonadotropins for their first superovulation cycle. Gonadotropins are fertility drugs that contain follicle stimulation hormone (FSH), luteinizing hormone (LH) or a combination of the two drugs. Synthetic gonadotropins and analogs are marketed by major pharmaceutical companies such as AstraZeneca, Sanofi-Aventis, Bayer AG, Pfizer and Abbott Laboratories.

For a woman going through infertility treatments, this natural hormone must be injected and cannot be taken orally, as they would be digested by the stomach. To date the injection has been conducted using needles, which is not only inconvenient but extremely painful. Using an alternative to needles, the Comfort-in™ Needle-Free Injection System will be a huge improvement for these patients. However, the medical community has to be confident the Needle-Free Injection device can deliver the same quantity of drugs to the patients as the regular needle. Therefore both ETAH and PCRM are launching these comprehensive, controlled clinical trials. The positive results of the clinical trials are essential for doctors to recommend such a device to their patients.

Dr. Hassan Salari, CEO of Eternity Healthcare, stated that "Eternity Healthcare has a Needle-Free Injection System, the Comfort-in™, which we believe is a viable solution for patients who do not like needles." He went on to state: "The Comfort-in™ is a mechanically operated system, easily used and highly affordable."

About Eternity Healthcare Inc. (ETAH)

Eternity Healthcare Inc. is a biopharmaceutical company with technologies in diagnostics and medical devices. We are currently focused on products to target diabetes needs, including a needle-free injection device. Our products are sold to healthcare professionals for use in physicians' offices, pharmacies, and to consumers directly. With a large number of additional diagnostic tests and medical devices for metabolic diseases, cardiovascular, neurodegenerative and cancer are under development at Eternity Healthcare Inc.

Safe Harbor Statement

This release includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as ETAH or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

Investor Relations Contact:
Wall Street Media Group Inc.
Bryan Andrew, 480-588-8658
View Comments (0)